Drug profile · INN
pralidoxime chloride
PRALIDOXIME CHLORIDE
pralidoxime chloride (PRALIDOXIME CHLORIDE) is a acetylcholinesterase activator. Route of administration: intramuscular. Current US regulatory status: approved.
Drug details — pralidoxime chloride
- US status
- approved
- Class
- —
- Route
- INTRAMUSCULAR
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
pralidoxime chloride (PRALIDOXIME CHLORIDE) is a acetylcholinesterase activator. Route of administration: intramuscular. Current US regulatory status: approved.
Key facts
Mechanism of action
Acetylcholinesterase activator
Primary target: Acetylcholinesterase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is pralidoxime chloride?
pralidoxime chloride (PRALIDOXIME CHLORIDE) is a acetylcholinesterase activator. Route of administration: intramuscular. Current US regulatory status: approved.
What is the brand name for pralidoxime chloride?
PRALIDOXIME CHLORIDE is a marketed brand name for pralidoxime chloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pralidoxime chloride?
pralidoxime chloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.